Acting Normal: US FDA's Unusual Interim Period Drags On
The messaging around the US FDA commissioner transition has emphasized continuity and business-as-usual. But this is still all pretty weird.
You may also be interested in...
Acting Commissioner Giroir Emphasizes 'Transitional' Period, Suggesting Time At US FDA Will Be Short
Giroir's memo to FDA staff also says intends to coordinate with prior acting commissioner Norman Sharpless to ensure current activities continue.
Upcoming proposed rule will create a process for third parties (notably including the state of Florida) to begin importing drugs wholesale from Canada. It will be an FDA rule – though FDA has had very little input in it.
Assistant HHS secretary for health has led policy development for several offices since his 2018 confirmation and also has industry and clinical experience.